GSK shares tumble 9% after Zantac ruling⚠️

5 months ago
20

#News #GSK #USA
Shares of GSK dropped more than 9% after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused cancer, to go forward, in a blow for the British drugmaker.

⚠️ TIME IS RUNNING OUT ⚠️

The truth is now being set free and things are about to get way more intense.

Defend what is right. Protect those you love. Don't back down no matter how hard you have to fight.

Follow with the notification on to see the next clip and click on it quickly in case they take it down.

▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬

▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬

Legal protection disclaimer all forms of content: My content is for entertainment only. In no event will I be liable for any loss or damage including, without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of my content on Rumble, YouTube, Reddit, Twitter, X account, Tik Tok, and anywhere else. My video content may change over time, or become outdated or invalid. I reserve the right to change my opinions and entertainment content at any time.

Loading comments...